The contribution of VEGF signalling to fostamatinib-induced blood pressure elevation
Author:
Affiliation:
1. AstraZeneca R&D; Macclesfield UK
2. AstraZeneca R&D; Waltham MA USA
3. AstraZeneca R&D; Mölndal Sweden
Publisher
Wiley
Subject
Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.12559/fullpdf
Reference52 articles.
1. The Concise Guide to PHARMACOLOGY 2013/14: Catalytic Receptors;Alexander;British Journal of Pharmacology,2013
2. Stimulus-specific blockade of nitric oxide-mediated dilatation by asymmetric dimethylarginine (ADMA) and monomethylarginine (L-NMMA) in rat aorta and carotid artery;Al-Zobaidy;Eur J Pharmacol,2011
3. Cardiovascular and systemic microvascular effects of anti-vascular endothelial growth factor therapy for cancer;Belcik;J Am Coll Cardiol,2012
4. VEGF kinase inhibitors: how do they cause hypertension?;Bhargava;Am J Physiol Regul Integr Comp Physiol,2009
5. Sunitinib, a receptor tyrosine kinase inhibitor, increases blood pressure in rats without associated changes in cardiac structure and function;Blasi;Cardiovasc Ther,2012
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Post-marketing safety surveillance of fostamatinib: an observational, pharmacovigilance study leveraging FAERS database;Expert Opinion on Drug Safety;2024-08
2. Comparison of electrocardiogram and blood pressure recording methods in non-rodent toxicology studies: A retrospective analysis;Journal of Pharmacological and Toxicological Methods;2024-07
3. The rat telemetry assay and venous catheter access buttons for use in cardiovascular safety pharmacology assessments – Surgical methods, refinements and colony maintenance;Journal of Pharmacological and Toxicological Methods;2024-05
4. Identification of new drugs to counteract anti-spike IgG-induced hyperinflammation in severe COVID-19;Life Science Alliance;2023-09-12
5. Characterisation of tyrosine kinase inhibitor-receptor interactions at VEGFR2 using sunitinib-red and nanoBRET;Biochemical Pharmacology;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3